142 related articles for article (PubMed ID: 19836653)
21. Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Flaig TW; Kim FJ; La Rosa FG; Breaker K; Schoen J; Russ PD
Invest New Drugs; 2009 Feb; 27(1):83-7. PubMed ID: 18563296
[No Abstract] [Full Text] [Related]
22. Sunitinib-induced hand-foot syndrome in a renal cell carcinoma: a sclerodermatous and rheumatoid arthritis-like case.
Ohtsuka T
J Dermatol; 2012 Nov; 39(11):943-4. PubMed ID: 22257303
[No Abstract] [Full Text] [Related]
23. Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy.
van der Veldt AA; van den Eertwegh AJ; Hoekman K; Barkhof F; Boven E
Ann Oncol; 2007 Oct; 18(10):1747-50. PubMed ID: 17890217
[No Abstract] [Full Text] [Related]
24. Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.
Szmit S; Nurzyński P; Szaluś N; Opolski G; Szczylik C
Acta Oncol; 2009; 48(6):921-5. PubMed ID: 19191048
[No Abstract] [Full Text] [Related]
25. Recurrent scrotal hemangiomas during treatment with sunitinib.
Tonini G; Intagliata S; Cagli B; Segreto F; Perrone G; Onetti Muda A; Santini D; Persichetti P
J Clin Oncol; 2010 Dec; 28(35):e737-8. PubMed ID: 20823408
[No Abstract] [Full Text] [Related]
26. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
Park CY
Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
[TBL] [Abstract][Full Text] [Related]
27. Sunitinib-induced acute hemolysis without hypertension: a case report.
Jain R; Mathew P; Wood CG; Tannir NM
Clin Genitourin Cancer; 2008 Sep; 6(2):122-3. PubMed ID: 18824436
[TBL] [Abstract][Full Text] [Related]
28. Guillain-Barré syndrome after treatment with sunitinib malate?
Mulherin B; Loconte NK; Holen KD
Oncology (Williston Park); 2008 Jan; 22(1):66-7, 70-1. PubMed ID: 18251284
[TBL] [Abstract][Full Text] [Related]
29. [Treatment with sunitinib and hypothyroidism--a case report and overview of literature].
Kreze A; Stáhalová V; Zadrazilová A; Koskuba J; Kosák M
Klin Onkol; 2009; 22(4):176-8. PubMed ID: 19731880
[TBL] [Abstract][Full Text] [Related]
30. Sunitinib-induced thyrotoxicosis.
Piñar D; Boix E; Meana JA; Herrero J
J Endocrinol Invest; 2009 Dec; 32(11):941-2. PubMed ID: 19636224
[No Abstract] [Full Text] [Related]
31. Palmar-plantar erythrodysesthesia secondary to sunitinib treatment resulting in necrotic foot syndrome aggravated by background diabetic vascular disease.
Guenova E; Weber HO; Voykov B; Metzler G; Mitev V; Berneburg M; Hoetzenecker W; Röcken M
Arch Dermatol; 2008 Aug; 144(8):1081-2. PubMed ID: 18711102
[No Abstract] [Full Text] [Related]
32. Pharmacokinetics of sunitinib in hemodialysis.
Izzedine H; Etienne-Grimaldi MC; Renée N; Vignot S; Milano G
Ann Oncol; 2009 Jan; 20(1):190-2. PubMed ID: 18801884
[No Abstract] [Full Text] [Related]
33. Extensive necrotizing fasciitis associated with sunitinib therapy.
Piszczek J; Dalton B; Peters T; Ruether D; Urbanski S
Clin Genitourin Cancer; 2014 Apr; 12(2):e47-9. PubMed ID: 24445249
[No Abstract] [Full Text] [Related]
34. Acute nephritic syndrome after anti-VEGF therapy for renal cell carcinoma.
Rolleman EJ; Weening J; Betjes MG
Nephrol Dial Transplant; 2009 Jun; 24(6):2002-3. PubMed ID: 19332867
[No Abstract] [Full Text] [Related]
35. Home blood-pressure monitoring in patients receiving sunitinib.
Azizi M; Chedid A; Oudard S
N Engl J Med; 2008 Jan; 358(1):95-7. PubMed ID: 18172185
[No Abstract] [Full Text] [Related]
36. [A case of pneumatosis cystoides intestinalis secondary to sunitinib treatment for renal cell carcinoma].
Ohtake S; Namura K; Fujikawa A; Sawada T; Ohta J; Moriyama M; Hayashi H
Hinyokika Kiyo; 2014 Feb; 60(2):75-8. PubMed ID: 24755817
[TBL] [Abstract][Full Text] [Related]
37. Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.
Alexandrescu DT; Popoveniuc G; Farzanmehr H; Dasanu CA; Dawson N; Wartofsky L
Thyroid; 2008 Jul; 18(7):809-12. PubMed ID: 18631016
[No Abstract] [Full Text] [Related]
38. Safety of multikinase inhibitors in metastatic renal cell carcinoma and indirect treatment comparisons.
Catalá-López F
Eur J Cancer; 2013 Mar; 49(4):984-5. PubMed ID: 23140823
[No Abstract] [Full Text] [Related]
39. Severe cardiomyopathy in a patient with renal cell carcinoma after treatment with the novel tyrosine kinase inhibitor sunitinib.
Chorianopoulos E; Jäger D; Katus HA; Frey N
Clin Res Cardiol; 2007 Nov; 96(11):829-30. PubMed ID: 17694380
[No Abstract] [Full Text] [Related]
40. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Rini BI; Tamaskar I; Shaheen P; Salas R; Garcia J; Wood L; Reddy S; Dreicer R; Bukowski RM
J Natl Cancer Inst; 2007 Jan; 99(1):81-3. PubMed ID: 17202116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]